Nahlawi A, Ptaszek L, Ruskin J
Nat Cardiovasc Res. 2025; 4(2):131-144.
PMID: 39910289
DOI: 10.1038/s44161-025-00608-2.
Golub D, White T, Shah H, Khaleghi M, Huntoon K, Zandbergen I
Pituitary. 2025; 28(1):28.
PMID: 39900842
DOI: 10.1007/s11102-025-01497-1.
Vandevelde M, Simoens A, Vandekerckhove B, Stevens C
RSC Med Chem. 2024; 15(3):998-1002.
PMID: 38516602
PMC: 10953488.
DOI: 10.1039/d4md00043a.
Gracan R, Blazevic S, Brizic M, Hranilovic D
Biomedicines. 2024; 12(2).
PMID: 38397959
PMC: 10887406.
DOI: 10.3390/biomedicines12020357.
Fordyce B, Roth B
Int J Neuropsychopharmacol. 2024; 27(2).
PMID: 38289825
PMC: 10888522.
DOI: 10.1093/ijnp/pyae007.
Whole proteome mapping of compound-protein interactions.
Chirasani V, Wang J, Sha C, Raup-Konsavage W, Vrana K, Dokholyan N
Curr Res Chem Biol. 2023; 2.
PMID: 38125869
PMC: 10732549.
DOI: 10.1016/j.crchbi.2022.100035.
New characterization of dihydroergotamine receptor pharmacology in the context of migraine: utilization of a β-arrestin recruitment assay.
McConnachie L, Goadsby P, Vann R, Ray S, Shrewsbury S, Aurora S
Front Neurol. 2023; 14:1282846.
PMID: 38073648
PMC: 10703426.
DOI: 10.3389/fneur.2023.1282846.
2B Determined: The Future of the Serotonin Receptor 2B in Drug Discovery.
Bender A, Parr L, Livingston W, Lindsley C, Merryman W
J Med Chem. 2023; 66(16):11027-11039.
PMID: 37584406
PMC: 11073569.
DOI: 10.1021/acs.jmedchem.3c01178.
Role of dopamine agonists in Parkinson's disease therapy.
Woitalla D, Buhmann C, Hilker-Roggendorf R, Hoglinger G, Koschel J, Muller T
J Neural Transm (Vienna). 2023; 130(6):863-873.
PMID: 37165120
DOI: 10.1007/s00702-023-02647-0.
Psychedelics: preclinical insights provide directions for future research.
Gumpper R, Roth B
Neuropsychopharmacology. 2023; 49(1):119-127.
PMID: 36932180
PMC: 10700551.
DOI: 10.1038/s41386-023-01567-7.
The evolving role of investigative toxicology in the pharmaceutical industry.
Pognan F, Beilmann M, Boonen H, Czich A, Dear G, Hewitt P
Nat Rev Drug Discov. 2023; 22(4):317-335.
PMID: 36781957
PMC: 9924869.
DOI: 10.1038/s41573-022-00633-x.
Binding and functional structure-activity similarities of 4-substituted 2,5-dimethoxyphenyl isopropylamine analogues at 5-HT and 5-HT serotonin receptors.
Hemanth P, Nistala P, Nguyen V, Eltit J, Glennon R, Dukat M
Front Pharmacol. 2023; 14:1101290.
PMID: 36762110
PMC: 9902381.
DOI: 10.3389/fphar.2023.1101290.
2-Phenethylamines in Medicinal Chemistry: A Review.
Nieto C, Manchado A, Belda L, Diez D, Garrido N
Molecules. 2023; 28(2).
PMID: 36677913
PMC: 9864394.
DOI: 10.3390/molecules28020855.
Heterotopic Transcatheter Tricuspid Valve Replacement in a Patient With Carcinoid Heart Disease.
Stolz L, Doldi P, Weckbach L, Schwinger R, Stocker T, Massberg S
JACC Case Rep. 2022; 4(23):101679.
PMID: 36438434
PMC: 9681668.
DOI: 10.1016/j.jaccas.2022.10.011.
The neural basis of psychedelic action.
Kwan A, Olson D, Preller K, Roth B
Nat Neurosci. 2022; 25(11):1407-1419.
PMID: 36280799
PMC: 9641582.
DOI: 10.1038/s41593-022-01177-4.
Bespoke library docking for 5-HT receptor agonists with antidepressant activity.
Kaplan A, Confair D, Kim K, Barros-Alvarez X, Rodriguiz R, Yang Y
Nature. 2022; 610(7932):582-591.
PMID: 36171289
PMC: 9996387.
DOI: 10.1038/s41586-022-05258-z.
Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD.
Cao C, Barros-Alvarez X, Zhang S, Kim K, Damgen M, Panova O
Neuron. 2022; 110(19):3154-3167.e7.
PMID: 36087581
PMC: 9583076.
DOI: 10.1016/j.neuron.2022.08.006.
Molecular Similarity Perception Based on Machine-Learning Models.
Gandini E, Marcou G, Bonachera F, Varnek A, Pieraccini S, Sironi M
Int J Mol Sci. 2022; 23(11).
PMID: 35682792
PMC: 9181189.
DOI: 10.3390/ijms23116114.
Psychedelics and Anti-inflammatory Activity in Animal Models.
Flanagan T, Nichols C
Curr Top Behav Neurosci. 2022; 56:229-245.
PMID: 35546383
DOI: 10.1007/7854_2022_367.
The promises and perils of psychedelic pharmacology for psychiatry.
McClure-Begley T, Roth B
Nat Rev Drug Discov. 2022; 21(6):463-473.
PMID: 35301459
DOI: 10.1038/s41573-022-00421-7.
